Delivery Order SPE2DE21D0017-SPE2D625F1SXC
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 15, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $2,412.12. This fixed-price contract with economic price adjustment was issued without a set-aside designation, indicating open competition. The award is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procurement of medical supplies to...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order with economic price adjustment on August 20, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. The contract, issued without set-aside designation, represents an open competition award and is funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and diagnostic...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $6,030.30 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test cards. This contract does not have a set-aside designation. The award is part of Abbott's existing indefinite-delivery, indefinite-quantity (IDIQ) contracts with the Department of Veterans Affairs and Department of Defense to supply diagnostic testing products and...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a delivery order valued at approximately $1.2 million to provide BINAXNOW COVID-19 antigen test cards. Performance will take place at Abbott's facility in Lockhart, Florida over a period of approximately three weeks from mid-September through early October 2023. The contract utilizes a fixed price with economic price adjustment pricing structure to deliver the...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $21.4 million firm fixed price delivery order to supply 8507767382 BINAXNOW COVID-19 antigen test cards. Under this contract, Abbott will deliver approximately 500,000 test cards to a location in Lockhart, Florida by November 9, 2020 to support the Department of Defense's medical response efforts to the coronavirus pandemic. As a leading provider of point-of-care...
- This federal contract award, valued at $1,206.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of BinaxNOW COVID-19 Ag Card test kits. The contract is a Delivery Order with a fixed-price structure and economic price adjustment, and has an ultimate completion date of November 13, 2024. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F1SXCDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,206.06 on August 22, 2025, for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment will be performed in Lockhart, Florida, with an ultimate completion date of September 15, 2025. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment for Department of Defense healthcare facilities and operations. This delivery order represents a continuation of Abbott Rapid DX North America LLC's established role as a key supplier of COVID-19 diagnostic products to federal healthcare agencies. The company maintains multiple indefinite delivery vehicles with various Veterans Integrated Service Networks and holds a GSA Schedule 65-VII contract specifically for in vitro diagnostics and COVID-19 testing supplies, demonstrating a consistent federal procurement relationship for point-of-care testing solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/22/25 |